Search

everythinglearnresearchcommunity

for

Search:↓

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

Alopecia areata treatment varies, with no optimal method established yet.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

Certain genes are linked to the risk of developing Alopecia Areata.